Read the report
APACMed and Bain & Company's report outlines how Asia-Pacific can lead the next wave of AI-powered medical innovation with Singapore as a strategic hub.
Artificial Intelligence (AI) is reshaping the medical technology (MedTech) industry, providing opportunities to transform patient care, boost operational efficiency, and unlock new business models.
“Establishing the Asia-Pacific Region as a MedTech AI Capability Hub” by APACMed and Bain & Company, provides actionable insights for MedTech companies that want to better use AI for innovation and growth. Supported by EDB, the report draws on insights from over 20 industry leaders and delves into:
Discover actionable insights and find out how businesses can tap into Asia-Pacific’s fast-growing MedTech AI ecosystem.
Also, visit EDB’s MedTech page to learn more about Singapore’s initiatives to support innovation and growth in this sector.
Read the report
APACMed and Bain & Company's report outlines how Asia-Pacific can lead the next wave of AI-powered medical innovation with Singapore as a strategic hub.